Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Icahn School of Medicine at Mount Sinai
New York, New York
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 124
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
James Ferrara | Conflict of Interest | Viracor | $5,000 - $9,999 | 2016 |
Alexander Grishin | Conflict of Interest | Allertein Therapeutics | $5,000 - $9,999 | 2019 |
Emma Guttman | Conflict of Interest | Pfizer | $5,000 - $9,999 | 2016 |
Bruce Sands | Conflict of Interest | Janssen Research and D& Development | $5,000 - $9,999 | 2017 |
Bruce Sands | Conflict of Interest | AbbVie, Inc. | $5,000 - $9,999 | 2017 |
Alison Goate | Conflict of Interest | Denali Therapeutics | $5,000 - $9,999 | 2018 |
James Krueger | Conflict of Interest | Pfizer | $5,000 - $9,999 | 2014 |
Marla Dubinsky | Conflict of Interest | Janssen Biotech | $5,000 - $9,999 | 2019 |
Bruce Sands | Conflict of Interest | Allergan, Inc. | $5,000 - $9,999 | 2017 |
Jeffrey Newcorn | Conflict of Interest | Shire | $5,000 - $9,999 | 2013 |
Jeffrey Newcorn | Conflict of Interest | Shire Pharmaceuticals | $5,000 - $9,999 | 2019 |
Robert Desnick | Conflict of Interest | Recordati Rare Diseases | $5,000 - $9,999 | 2017 |
Tom Michoel | Conflict of Interest | Clinical Gene Networks | $5,000 - $9,999 | 2016 |
Jeffrey Newcorn | Conflict of Interest | Sunovian Pharmaceuticals Inc. | $5,000 - $9,999 | 2014 |
Bruce Sands | Conflict of Interest | Janssen Biotech | $5,000 - $9,999 | 2019 |
Bruce Sands | Conflict of Interest | Takeda Pharmaceutical Company Limited | $5,000 - $9,999 | 2017 |
Jean-Fredsereic Colombel | Conflict of Interest | Allergan | $5,000 - $9,999 | 2019 |
Jean-Frederic Colombel | Conflict of Interest | Janssen | $5,000 - $9,999 | 2019 |
Jeffrey Newcorn | Conflict of Interest | Sunovion Pharmaceuticals | $5,000 - $9,999 | 2018 |
Jean-Frederick Colombel | Conflict of Interest | Shire | $5,000 - $9,999 | 2019 |
Douglas Dieterich | Conflict of Interest | Bristol-Meyers Squibb | $0 - $4,999 | 2014 |
Jean Frederic Colombel | Conflict of Interest | Janssen Biotech | $0 - $4,999 | 2019 |
Douglas Dieterich | Conflict of Interest | AbbVie | $0 - $4,999 | 2014 |
Douglas Dieterich | Conflict of Interest | Genentech Inc. | $0 - $4,999 | 2014 |
Douglas Dieterich | Conflict of Interest | Boehringer Ingelheim Corp | $0 - $4,999 | 2014 |
Douglas Dieterich | Conflict of Interest | Idenix Pharmaceuticals | $0 - $4,999 | 2014 |
R. L. Ehman, | Conflict of Interest | Mayo Clinic | $0 - $4,999 | 2018 |
Eric Schadt | Conflict of Interest | Clinical Gene Networks | $0 - $4,999 | 2016 |
Judy Cho | Conflict of Interest | University of Michigan | $0 - $4,999 | 2015 |
Kevin Glaser | Conflict of Interest | Mayo Clinic | $0 - $4,999 | 2018 |
Jeffrey Newcorn | Conflict of Interest | Enzymotec | $0 - $4,999 | 2018 |
Jeffrey Newcorn | Conflict of Interest | Alcobra Ltd | $0 - $4,999 | 2013 |
Jeffrey Newcorn | Conflict of Interest | GencoSciences LLC | $0 - $4,999 | 2013 |
Jeffrey Newcorn | Conflict of Interest | BioBDx | $0 - $4,999 | 2013 |
John Levine | Conflict of Interest | Viracor | $0 - $4,999 | 2018 |
Priti Balchandani | Conflict of Interest | Philips International | $0 - $4,999 | 2016 |
Priti Balchandani | Conflict of Interest | GE Healthcare | $0 - $4,999 | 2016 |
Priti Balchandani | Conflict of Interest | Siemens AG | $0 - $4,999 | 2016 |
Stephen Cusack | Conflict of Interest | Savira Pharmaceutical | $0 - $4,999 | 2017 |
Stephen Ellis | Conflict of Interest | Ontomics | $0 - $4,999 | 2017 |
Andrew Vickers | Conflict of Interest | OPKO Health | $0 - $4,999 | 2015 |
M.v. Ramana Reddy | Conflict of Interest | Onconova Therapeutics, Inc. | $0 - $4,999 | 2013 |
Ashish Atreja | Conflict of Interest | Responsive Health | $0 - $4,999 | 2017 |
Eric Schadt | Conflict of Interest | Clinical Gene Networks | $0 - $4,999 | 2016 |
Erwin Bottinger | Conflict of Interest | Ontomics | $0 - $4,999 | 2017 |
Ramon Parsons | Conflict of Interest | TheraPten | $0 - $4,999 | 2019 |
Stephen Ellis | Conflict of Interest | Ontomics | $0 - $4,999 | 2017 |
Eric Schadt | Conflict of Interest | Sema4 | 2019 | |
Eric Schadt | Conflict of Interest | Sema4 | 2019 | |
Adolfo Garcia-Sastre | Conflict of Interest | Vivaldi Biosciences | 2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.